机构：[1]Capital Med Univ, Beijing Ditan Hosp, Dept Med Oncol, Beijing, Peoples R China[2]Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China临床科室肿瘤内科河北医科大学第四医院[3]Hebei Med Univ, Hosp 4, Dept Gastroenterol, Shijiazhuang, Hebei, Peoples R China临床科室消化内科河北医科大学第四医院[4]Hebei Med Univ, Hosp 4, Dept Hepatobiliary Surg, Shijiazhuang, Hebei, Peoples R China临床科室肝胆外科河北医科大学第四医院[5]Tangshan Gongren Hosp, Dept Hepatobiliary Surg, Tangshan, Peoples R China[6]Tianjin Third Cent Hosp, Dept Hepatol Surg, Tianjin, Peoples R China[7]Shanxi Med Univ, Hosp 1, Taiyuan, Peoples R China[8]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院[9]OrigiMed, Shanghai, Peoples R China[10]OrigiMed, Dept Med, Shanghai, Peoples R China[11]Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
Li Wendong,Cui Yanzhi,Yin Fei,et al.BRAF mutation in Chinese biliary tract cancer patients.[J].JOURNAL OF CLINICAL ONCOLOGY.2020,38(15):
APA：
Li, Wendong,Cui, Yanzhi,Yin, Fei,Peng, Li,Liu, Xiaogang...&Jiang, Da.(2020).BRAF mutation in Chinese biliary tract cancer patients..JOURNAL OF CLINICAL ONCOLOGY,38,(15)
MLA：
Li, Wendong,et al."BRAF mutation in Chinese biliary tract cancer patients.".JOURNAL OF CLINICAL ONCOLOGY 38..15(2020)
医学